200 related articles for article (PubMed ID: 26360017)
21. Chemoradiation with paclitaxel and carboplatin in high-risk cervical cancer patients after radical hysterectomy: a Korean Gynecologic Oncology Group study.
Lee TS; Kang SB; Kim YT; Park BJ; Kim YM; Lee JM; Kim SM; Kim YT; Kim JH; Kim KT
Int J Radiat Oncol Biol Phys; 2013 Jun; 86(2):304-10. PubMed ID: 23642625
[TBL] [Abstract][Full Text] [Related]
22. Ten-year survival of patients with locally advanced, stage ib-iib cervical cancer after neoadjuvant chemotherapy and radical hysterectomy.
Hwang YY; Moon H; Cho SH; Kim KT; Moon YJ; Kim SR; Kim DS
Gynecol Oncol; 2001 Jul; 82(1):88-93. PubMed ID: 11426967
[TBL] [Abstract][Full Text] [Related]
23. Prognostic value of combined serum biomarkers in predicting outcomes in cervical cancer patients.
Li J; Cheng H; Zhang P; Dong Z; Tong HL; Han JD; Guo F; Tian YP
Clin Chim Acta; 2013 Sep; 424():292-7. PubMed ID: 23850705
[TBL] [Abstract][Full Text] [Related]
24. Adenosquamous carcinoma of the cervix: prognosis in early stage disease treated by radical hysterectomy.
Harrison TA; Sevin BU; Koechli O; Nguyen HN; Averette HE; Penalver M; Donato DM; Nadji M
Gynecol Oncol; 1993 Sep; 50(3):310-5. PubMed ID: 8406193
[TBL] [Abstract][Full Text] [Related]
25. Distinctive clinicopathologic characteristics and prognosis for different histologic subtypes of early cervical cancer.
Cao L; Wen H; Feng Z; Han X; Wu X
Int J Gynecol Cancer; 2019 Oct; 29(8):1244-1251. PubMed ID: 31422351
[TBL] [Abstract][Full Text] [Related]
26. A comparison of prognoses of pathologic stage Ib adenocarcinoma and squamous cell carcinoma of the uterine cervix.
Nakanishi T; Ishikawa H; Suzuki Y; Inoue T; Nakamura S; Kuzuya K
Gynecol Oncol; 2000 Nov; 79(2):289-93. PubMed ID: 11063659
[TBL] [Abstract][Full Text] [Related]
27. Utility of risk-weighted surgical-pathological factors in early-stage cervical cancer.
Matsuo K; Mabuchi S; Okazawa M; Matsumoto Y; Tsutsui T; Fujita M; Kamiura S; Ogawa K; Morrow CP; Kimura T
Br J Cancer; 2013 Apr; 108(6):1348-57. PubMed ID: 23462721
[TBL] [Abstract][Full Text] [Related]
28. Influence of treatment center and hospital volume on survival for locally advanced cervical cancer.
Wright JD; Huang Y; Ananth CV; Tergas AI; Duffy C; Deutsch I; Burke WM; Hou JY; Neugut AI; Hershman DL
Gynecol Oncol; 2015 Dec; 139(3):506-12. PubMed ID: 26177552
[TBL] [Abstract][Full Text] [Related]
29. Prognostic value of preoperative squamous cell carcinoma antigen level in patients surgically treated for cervical carcinoma.
Bolger BS; Dabbas M; Lopes A; Monaghan JM
Gynecol Oncol; 1997 May; 65(2):309-13. PubMed ID: 9159343
[TBL] [Abstract][Full Text] [Related]
30. Dynamic contrast-enhanced MRI of cervical cancers: temporal percentile screening of contrast enhancement identifies parameters for prediction of chemoradioresistance.
Andersen EK; Hole KH; Lund KV; Sundfør K; Kristensen GB; Lyng H; Malinen E
Int J Radiat Oncol Biol Phys; 2012 Mar; 82(3):e485-92. PubMed ID: 22014954
[TBL] [Abstract][Full Text] [Related]
31. Occult invasive cervical cancer found after inadvertent simple hysterectomy: is the ideal management: systematic parametrectomy with or without radiotherapy or radiotherapy only?
Narducci F; Merlot B; Bresson L; Katdare N; Le Tinier F; Cordoba A; Fournier C; Leblanc E
Ann Surg Oncol; 2015 Apr; 22(4):1349-52. PubMed ID: 25297903
[TBL] [Abstract][Full Text] [Related]
32. Postoperative radiotherapy for uterine cervical cancer: impact of lymph node and histological type on survival.
Kasuya G; Ogawa K; Iraha S; Nagai Y; Hirakawa M; Toita T; Kakinohana Y; Kudaka W; Inamine M; Ariga T; Aoki Y; Murayama S
Anticancer Res; 2013 May; 33(5):2199-204. PubMed ID: 23645776
[TBL] [Abstract][Full Text] [Related]
33. Undetected human papillomavirus DNA and uterine cervical carcinoma: Association with cancer recurrence.
Okuma K; Yamashita H; Yokoyama T; Nakagawa K; Kawana K
Strahlenther Onkol; 2016 Jan; 192(1):55-62. PubMed ID: 26481139
[TBL] [Abstract][Full Text] [Related]
34. A population-based survey of the management of women with cancer of the cervix.
Clarke F; Dey P; Collins S
Br J Cancer; 1999 Aug; 80(12):1958-61. PubMed ID: 10471045
[TBL] [Abstract][Full Text] [Related]
35. Is there a role for postoperative treatment in patients with stage Ib2-IIb cervical cancer treated with neo-adjuvant chemotherapy and radical surgery? An Italian multicenter retrospective study.
Landoni F; Sartori E; Maggino T; Zola P; Zanagnolo V; Cosio S; Ferrari F; Piovano E; Gadducci A
Gynecol Oncol; 2014 Mar; 132(3):611-7. PubMed ID: 24342439
[TBL] [Abstract][Full Text] [Related]
36. Treatment outcomes of locally advanced cervical cancer by histopathological types in a single institution: A propensity score matching study.
Yin KC; Lu CH; Lin JC; Hsu CY; Wang L
J Formos Med Assoc; 2018 Oct; 117(10):922-931. PubMed ID: 30025761
[TBL] [Abstract][Full Text] [Related]
37. Adenosquamous histology predicts a poor outcome for patients with advanced-stage, but not early-stage, cervical carcinoma.
Farley JH; Hickey KW; Carlson JW; Rose GS; Kost ER; Harrison TA
Cancer; 2003 May; 97(9):2196-202. PubMed ID: 12712471
[TBL] [Abstract][Full Text] [Related]
38. Survival after curative pelvic exenteration for primary or recurrent cervical cancer: a retrospective multicentric study of 167 patients.
Chiantera V; Rossi M; De Iaco P; Koehler C; Marnitz S; Ferrandina G; Legge F; Parazzini F; Scambia G; Schneider A; Vercellino GF
Int J Gynecol Cancer; 2014 Jun; 24(5):916-22. PubMed ID: 24442006
[TBL] [Abstract][Full Text] [Related]
39. Therapeutic outcome and prognostic factors in the radiotherapy of recurrences of cervical carcinoma following surgery.
Hille A; Weiss E; Hess CF
Strahlenther Onkol; 2003 Nov; 179(11):742-7. PubMed ID: 14605743
[TBL] [Abstract][Full Text] [Related]
40. Outcome analysis of cervical adenosquamous carcinoma compared with adenocarcinoma.
Chen JL; Cheng JC; Kuo SH; Chen CA; Lin MC; Huang CY
Acta Obstet Gynecol Scand; 2012 Oct; 91(10):1158-66. PubMed ID: 22497449
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
